(BROS) Dutch Bros - Ratings and Ratios
Coffee, Energy Drink, Smoothies, Shakes
EPS (Earnings per Share)
Revenue
Dividends
Currently no dividends paid| Risk via 5d forecast | |
|---|---|
| Volatility | 53.4% |
| Value at Risk 5%th | 72.9% |
| Relative Tail Risk | -16.99% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.37 |
| Alpha | -14.12 |
| CAGR/Max DD | 0.48 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.480 |
| Beta | 1.617 |
| Beta Downside | 1.763 |
| Drawdowns 3y | |
|---|---|
| Max DD | 44.17% |
| Mean DD | 22.50% |
| Median DD | 25.19% |
Description: BROS Dutch Bros January 03, 2026
Dutch Bros Inc. (NYSE:BROS) operates a network of drive-thru coffee shops across the United States, split between Company-Operated Shops and franchised locations. The brand portfolio includes Dutch Bros, Dutch Bros Coffee, Dutch Bros Rebel, and Blue Rebel, all sold primarily through physical drive-thru outlets and online ordering channels.
Founded in 1992 and headquartered in Grants Pass, Oregon, the company reported FY 2023 revenue of approximately $1.5 billion and grew its store count to roughly 800 locations, with franchisees now accounting for about 30 percent of total outlets. Same-store sales rose ~15 percent year-over-year, driven by higher average ticket size (≈ $7.20) and strong demand for the higher-margin Rebel energy-drink line.
Key economic drivers for Dutch Bros include discretionary consumer spending trends, coffee bean price volatility, and labor-cost inflation-factors that disproportionately affect drive-thru concepts with lower overhead than full-service cafés. At the sector level, the continued shift toward on-the-go coffee consumption and the expansion of franchise models are boosting scalability and cash-flow generation for players like Dutch Bros.
For a deeper, data-rich analysis of Dutch Bros’ valuation and scenario modeling, consult the ValueRay platform.
Piotroski VR‑10 (Strict, 0-10) 6.5
| Net Income (62.1m TTM) > 0 and > 6% of Revenue (6% = 92.2m TTM) |
| FCFTA 0.02 (>2.0%) and ΔFCFTA 2.67pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 7.59% (prev 13.55%; Δ -5.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.10 (>3.0%) and CFO 278.1m > Net Income 62.1m (YES >=105%, WARN >=100%) |
| Net Debt (769.4m) to EBITDA (239.2m) ratio: 3.22 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.52 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (127.4m) change vs 12m ago 11.49% (target <= -2.0% for YES) |
| Gross Margin 26.33% (prev 26.10%; Δ 0.23pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 57.43% (prev 49.04%; Δ 8.40pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 5.09 (EBITDA TTM 239.2m / Interest Expense TTM 27.4m) >= 6 (WARN >= 3) |
Altman Z'' 0.74
| (A) 0.04 = (Total Current Assets 341.1m - Total Current Liabilities 224.5m) / Total Assets 2.92b |
| (B) 0.03 = Retained Earnings (Balance) 78.1m / Total Assets 2.92b |
| (C) 0.05 = EBIT TTM 139.3m / Avg Total Assets 2.68b |
| (D) 0.04 = Book Value of Equity 78.3m / Total Liabilities 2.06b |
| Total Rating: 0.74 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 65.45
| 1. Piotroski 6.50pt |
| 2. FCF Yield 0.59% |
| 3. FCF Margin 4.25% |
| 4. Debt/Equity 1.58 |
| 5. Debt/Ebitda 3.22 |
| 6. ROIC - WACC (= 2.07)% |
| 7. RoE 10.22% |
| 8. Rev. Trend 98.30% |
| 9. EPS Trend 49.04% |
What is the price of BROS shares?
Over the past week, the price has changed by +3.25%, over one month by +8.83%, over three months by +32.63% and over the past year by +9.87%.
Is BROS a buy, sell or hold?
- Strong Buy: 10
- Buy: 5
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the BROS price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 76.6 | 21.2% |
| Analysts Target Price | 76.6 | 21.2% |
| ValueRay Target Price | 65.5 | 3.7% |
BROS Fundamental Data Overview January 04, 2026
P/E Trailing = 126.8571
P/E Forward = 68.9655
P/S = 6.655
P/B = 11.8449
Beta = 2.56
Revenue TTM = 1.54b USD
EBIT TTM = 139.3m USD
EBITDA TTM = 239.2m USD
Long Term Debt = 196.0m USD (from longTermDebt, last quarter)
Short Term Debt = 36.5m USD (from shortTermDebt, last quarter)
Debt = 1.04b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 769.4m USD (from netDebt column, last quarter)
Enterprise Value = 11.00b USD (10.23b + Debt 1.04b - CCE 267.2m)
Interest Coverage Ratio = 5.09 (Ebit TTM 139.3m / Interest Expense TTM 27.4m)
FCF Yield = 0.59% (FCF TTM 65.4m / Enterprise Value 11.00b)
FCF Margin = 4.25% (FCF TTM 65.4m / Revenue TTM 1.54b)
Net Margin = 4.04% (Net Income TTM 62.1m / Revenue TTM 1.54b)
Gross Margin = 26.33% ((Revenue TTM 1.54b - Cost of Revenue TTM 1.13b) / Revenue TTM)
Gross Margin QoQ = 25.21% (prev 28.87%)
Tobins Q-Ratio = 3.76 (Enterprise Value 11.00b / Total Assets 2.92b)
Interest Expense / Debt = 0.65% (Interest Expense 6.70m / Debt 1.04b)
Taxrate = 21.92% (7.66m / 34.9m)
NOPAT = 108.8m (EBIT 139.3m * (1 - 21.92%))
Current Ratio = 1.52 (Total Current Assets 341.1m / Total Current Liabilities 224.5m)
Debt / Equity = 1.58 (Debt 1.04b / totalStockholderEquity, last quarter 656.6m)
Debt / EBITDA = 3.22 (Net Debt 769.4m / EBITDA 239.2m)
Debt / FCF = 11.76 (Net Debt 769.4m / FCF TTM 65.4m)
Total Stockholder Equity = 607.3m (last 4 quarters mean from totalStockholderEquity)
RoA = 2.12% (Net Income 62.1m / Total Assets 2.92b)
RoE = 10.22% (Net Income TTM 62.1m / Total Stockholder Equity 607.3m)
RoCE = 17.34% (EBIT 139.3m / Capital Employed (Equity 607.3m + L.T.Debt 196.0m))
RoIC = 12.99% (NOPAT 108.8m / Invested Capital 837.6m)
WACC = 10.92% (E(10.23b)/V(11.27b) * Re(11.97%) + D(1.04b)/V(11.27b) * Rd(0.65%) * (1-Tc(0.22)))
Discount Rate = 11.97% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 41.42%
[DCF Debug] Terminal Value 55.04% ; FCFE base≈65.4m ; Y1≈42.9m ; Y5≈19.6m
Fair Price DCF = 1.83 (DCF Value 232.8m / Shares Outstanding 127.0m; 5y FCF grow -40.0% → 3.0% )
EPS Correlation: 49.04 | EPS CAGR: 8.38% | SUE: -4.0 | # QB: 0
Revenue Correlation: 98.30 | Revenue CAGR: 34.32% | SUE: 1.31 | # QB: 6
EPS next Quarter (2026-03-31): EPS=0.18 | Chg30d=+0.003 | Revisions Net=+2 | Analysts=16
EPS next Year (2026-12-31): EPS=0.90 | Chg30d=+0.008 | Revisions Net=+2 | Growth EPS=+33.4% | Growth Revenue=+25.7%
Additional Sources for BROS Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle